News | September 25, 2024
Nadda asked NMC to add 75,000 medical seats
NMC to continue its efforts to improve and enhance the quality of medical education in the country
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
Total investment incurred for setting up the new R&D Rs 250 crore
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
Subscribe To Our Newsletter & Stay Updated
